Basal and FSH-stimulated levels of AMH, might become a useful predictive marker of the spermatogenic response to gonadotropic treatment in young patients with hypogonadotropic hypogonadism. The gene discussed is BRD2; the disease is hypogonadotropic hypogonadism.